Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir

NCT01173913 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: ModraDoc001 10mg capsules
DRUG: ModraDoc003 10mg tablets and ModraDoc004 10/50 mg
DRUG: ModraDoc006 10 mg tablet

Sponsor

The Netherlands Cancer Institute